ALB and myeloid sarcoma: In the <25 kg/m2 BMI group, age, BMI, WHtR, cardiovascular disease, MS, eGFR, hemoglobin level, albumin level, CRP level, triglyceride level, and all-cause mortality increased with TBF%, but progression to ESRD and Upcr decreased.